{"transactions":[{"id":4624150,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-18T20:36:21.000Z","date":"2026-09-17","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 18, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":43818,"derivative":{"exercise_price":17.88,"expiration_date":"2034-01-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001273351-26-000006","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000127335126000006/ownership.xml","form_type":"4"}},{"id":4624149,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-09-18T20:36:21.000Z","date":"2026-09-17","kind":"sale","planned":true,"acquired":false,"shares":700,"price":104.39,"value":73073.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 18, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $104.17 to $104.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001273351-26-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000127335126000006/ownership.xml","form_type":"4"}},{"id":4624148,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-09-18T20:36:21.000Z","date":"2026-09-17","kind":"sale","planned":true,"acquired":false,"shares":1100,"price":103.2,"value":113520.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 18, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $103.05 to $103.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":700,"source":{"system":"sec-edgar","filing":"0001273351-26-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000127335126000006/ownership.xml","form_type":"4"}},{"id":4624147,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-09-18T20:36:21.000Z","date":"2026-09-17","kind":"sale","planned":true,"acquired":false,"shares":3501,"price":102.39,"value":358467.39,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 18, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $101.99 to $102.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1800,"source":{"system":"sec-edgar","filing":"0001273351-26-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000127335126000006/ownership.xml","form_type":"4"}},{"id":4624146,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-09-18T20:36:21.000Z","date":"2026-09-17","kind":"sale","planned":true,"acquired":false,"shares":6771,"price":101.37,"value":686376.27,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 18, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $100.99 to $101.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":5301,"source":{"system":"sec-edgar","filing":"0001273351-26-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000127335126000006/ownership.xml","form_type":"4"}},{"id":4624145,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-09-18T20:36:21.000Z","date":"2026-09-17","kind":"sale","planned":true,"acquired":false,"shares":7928,"price":100.43,"value":796209.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 18, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $99.98 to $100.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":12072,"source":{"system":"sec-edgar","filing":"0001273351-26-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000127335126000006/ownership.xml","form_type":"4"}},{"id":4624144,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-09-18T20:36:21.000Z","date":"2026-09-17","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":17.88,"value":357600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 18, 2026."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001273351-26-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000127335126000006/ownership.xml","form_type":"4"}},{"id":843910,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-14T00:30:05.000Z","date":"2026-03-12","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after May 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":50000,"derivative":{"exercise_price":21.77,"expiration_date":"2034-05-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001273351-26-000004","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000127335126000004/ownership.xml","form_type":"4"}},{"id":843909,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-14T00:30:05.000Z","date":"2026-03-12","kind":"exercise","planned":true,"acquired":false,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":42500,"derivative":{"exercise_price":22.07,"expiration_date":"2035-02-03","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001273351-26-000004","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000127335126000004/ownership.xml","form_type":"4"}},{"id":843908,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-14T00:30:05.000Z","date":"2026-03-12","kind":"exercise","planned":true,"acquired":false,"shares":16182,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":63818,"derivative":{"exercise_price":17.88,"expiration_date":"2034-01-23","underlying":"Common Stock","underlying_shares":16182},"source":{"system":"sec-edgar","filing":"0001273351-26-000004","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000127335126000004/ownership.xml","form_type":"4"}},{"id":843907,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-03-14T00:30:05.000Z","date":"2026-03-12","kind":"sale","planned":true,"acquired":false,"shares":300,"price":85.53,"value":25659.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2025."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001273351-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000127335126000004/ownership.xml","form_type":"4"}},{"id":843906,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-03-14T00:30:05.000Z","date":"2026-03-12","kind":"sale","planned":true,"acquired":false,"shares":200,"price":83.38,"value":16676.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2025."}],"balance_after":300,"source":{"system":"sec-edgar","filing":"0001273351-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000127335126000004/ownership.xml","form_type":"4"}},{"id":843905,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-03-14T00:30:05.000Z","date":"2026-03-12","kind":"sale","planned":true,"acquired":false,"shares":3865,"price":82.66,"value":319480.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $82.34 to $83.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":500,"source":{"system":"sec-edgar","filing":"0001273351-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000127335126000004/ownership.xml","form_type":"4"}},{"id":843904,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-03-14T00:30:05.000Z","date":"2026-03-12","kind":"sale","planned":true,"acquired":false,"shares":23465,"price":81.75,"value":1918263.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $81.30 to $82.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":4365,"source":{"system":"sec-edgar","filing":"0001273351-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000127335126000004/ownership.xml","form_type":"4"}},{"id":843903,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-03-14T00:30:05.000Z","date":"2026-03-12","kind":"sale","planned":true,"acquired":false,"shares":15852,"price":80.71,"value":1279414.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $80.30 to $81.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":27830,"source":{"system":"sec-edgar","filing":"0001273351-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000127335126000004/ownership.xml","form_type":"4"}},{"id":843902,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-03-14T00:30:05.000Z","date":"2026-03-12","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":21.77,"value":217700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2025."}],"balance_after":43682,"source":{"system":"sec-edgar","filing":"0001273351-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000127335126000004/ownership.xml","form_type":"4"}},{"id":843901,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-03-14T00:30:05.000Z","date":"2026-03-12","kind":"exercise","planned":true,"acquired":true,"shares":17500,"price":22.07,"value":386225.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2025."}],"balance_after":33682,"source":{"system":"sec-edgar","filing":"0001273351-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000127335126000004/ownership.xml","form_type":"4"}},{"id":843900,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Common Stock","published_at":"2026-03-14T00:30:05.000Z","date":"2026-03-12","kind":"exercise","planned":true,"acquired":true,"shares":16182,"price":17.88,"value":289334.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2025."}],"balance_after":16182,"source":{"system":"sec-edgar","filing":"0001273351-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000127335126000004/ownership.xml","form_type":"4"}},{"id":919421,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-04T22:42:10.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying this stock option award will vest in equal monthly installments over the four years after January 1, 2026, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":55000,"derivative":{"exercise_price":52.46,"expiration_date":"2036-02-03","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001273351-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000127335126000002/ownership.xml","form_type":"4"}},{"id":1284871,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-04T21:27:25.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying this stock option award will vest in equal monthly installments over the four years after January 1, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":60000,"derivative":{"exercise_price":22.07,"expiration_date":"2035-02-02","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000950170-25-013516","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000095017025013516/ownership.xml","form_type":"4"}},{"id":1500441,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-29T00:05:38.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying this stock option award will vest in equal monthly installments over the four years after May 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":60000,"derivative":{"exercise_price":21.77,"expiration_date":"2034-05-22","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000950170-24-065567","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000095017024065567/ownership.xml","form_type":"4"}},{"id":1669543,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF ACCOUNTING OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-26T21:51:02.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying this stock option award will vest in equal monthly installments over the four years after January 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":80000,"derivative":{"exercise_price":17.88,"expiration_date":"2034-01-23","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0000950170-24-008000","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000095017024008000/ownership.xml","form_type":"4"}},{"id":2545912,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock","published_at":"2021-10-09T00:29:14.000Z","date":"2021-10-08","kind":"sale","acquired":false,"shares":29122,"price":1.0506,"value":30595.5732,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were used solely to cover tax obligations associated with vested restricted stock awards and were effected pursuant to a Rule 10b5-1 trading plan adopted by Edward Carr on February 23, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.84 to $1.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote."}],"balance_after":400169,"source":{"system":"sec-edgar","filing":"0001493152-21-025082","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221025082/ownership.xml","form_type":"4"}},{"id":2606086,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-12T20:05:48.000Z","date":"2021-08-10","kind":"grant","acquired":true,"shares":476000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest 25% on August 10, 2022, and in 36 equal monthly installments thereafter."}],"balance_after":476000,"derivative":{"exercise_price":1.26,"expiration_date":"2031-08-10","underlying":"Common Stock","underlying_shares":476000},"source":{"system":"sec-edgar","filing":"0001493152-21-019498","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221019498/ownership.xml","form_type":"4"}},{"id":2606085,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common stock","published_at":"2021-08-12T20:05:48.000Z","date":"2021-08-10","kind":"grant","acquired":true,"shares":238000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest 25% on each of August 10, 2022, August 10, 2023, August 10, 2024 and August 10, 2025."}],"balance_after":429291,"source":{"system":"sec-edgar","filing":"0001493152-21-019498","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221019498/ownership.xml","form_type":"4"}},{"id":2759699,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common stock","published_at":"2021-04-05T22:31:30.000Z","date":"2021-04-05","kind":"sale","acquired":false,"shares":35000,"price":1.7956,"value":62846.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Edward Carr on February 23, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.76 to $1.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote."}],"balance_after":191291,"source":{"system":"sec-edgar","filing":"0001493152-21-008025","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221008025/ownership.xml","form_type":"4"}},{"id":2759698,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common stock","published_at":"2021-04-05T22:31:30.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":20445,"price":1.8521,"value":37866.1845,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Edward Carr on February 23, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.7893 to $1.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder, or the Staff of the SEC, upon request, full information regarding the number of shares disposed at each separate price within the ranges set forth in this footnote."}],"balance_after":226291,"source":{"system":"sec-edgar","filing":"0001493152-21-008025","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221008025/ownership.xml","form_type":"4"}},{"id":2817036,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-03T21:05:43.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest 25% on March 1, 2022, and in 36 equal monthly installments thereafter."}],"balance_after":100000,"derivative":{"exercise_price":2.34,"expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-21-005274","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221005274/ownership.xml","form_type":"4"}},{"id":2817035,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common stock","published_at":"2021-03-03T21:05:43.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest 25% on each of March 1, 2022, March 1, 2023, March 1, 2024 and March 1, 2025."}],"balance_after":246736,"source":{"system":"sec-edgar","filing":"0001493152-21-005274","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221005274/ownership.xml","form_type":"4"}},{"id":2972220,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:12.000Z","date":"2020-11-20","kind":"disposition_to_issuer","acquired":false,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on March 16, 2020, May 20, 2020, April 9, 2019, and November 19, 2018 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest 25% on November 19, 2019, and in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":8.54,"expiration_date":"2028-11-19","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001493152-20-022148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022148/ownership.xml","form_type":"4"}},{"id":2972219,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:12.000Z","date":"2020-11-20","kind":"grant","acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on March 16, 2020, May 20, 2020, April 9, 2019, and November 19, 2018 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest 25% on November 19, 2019, and in 36 equal monthly installments thereafter."}],"balance_after":35000,"derivative":{"exercise_price":1.15,"expiration_date":"2028-11-19","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001493152-20-022148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022148/ownership.xml","form_type":"4"}},{"id":2972218,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:12.000Z","date":"2020-11-20","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on March 16, 2020, May 20, 2020, April 9, 2019, and November 19, 2018 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest 25% on April 9, 2020, and in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":7.24,"expiration_date":"2029-04-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-20-022148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022148/ownership.xml","form_type":"4"}},{"id":2972217,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:12.000Z","date":"2020-11-20","kind":"grant","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on March 16, 2020, May 20, 2020, April 9, 2019, and November 19, 2018 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest 25% on April 9, 2020, and in 36 equal monthly installments thereafter."}],"balance_after":10000,"derivative":{"exercise_price":1.15,"expiration_date":"2029-04-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-20-022148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022148/ownership.xml","form_type":"4"}},{"id":2972216,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:12.000Z","date":"2020-11-20","kind":"disposition_to_issuer","acquired":false,"shares":51081,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on March 16, 2020, May 20, 2020, April 9, 2019, and November 19, 2018 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":1.45,"expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":51081},"source":{"system":"sec-edgar","filing":"0001493152-20-022148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022148/ownership.xml","form_type":"4"}},{"id":2972215,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:12.000Z","date":"2020-11-20","kind":"grant","acquired":true,"shares":51081,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on March 16, 2020, May 20, 2020, April 9, 2019, and November 19, 2018 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter."}],"balance_after":51081,"derivative":{"exercise_price":1.15,"expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":51081},"source":{"system":"sec-edgar","filing":"0001493152-20-022148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022148/ownership.xml","form_type":"4"}},{"id":2972214,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:12.000Z","date":"2020-11-20","kind":"disposition_to_issuer","acquired":false,"shares":28919,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on March 16, 2020, May 20, 2020, April 9, 2019, and November 19, 2018 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter."}],"balance_after":0,"derivative":{"exercise_price":3.2,"expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":28919},"source":{"system":"sec-edgar","filing":"0001493152-20-022148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022148/ownership.xml","form_type":"4"}},{"id":2972213,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-11-20T23:00:12.000Z","date":"2020-11-20","kind":"grant","acquired":true,"shares":28919,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options granted on March 16, 2020, May 20, 2020, April 9, 2019, and November 19, 2018 have each been modified to reflect a lower exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter."}],"balance_after":28919,"derivative":{"exercise_price":1.15,"expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":28919},"source":{"system":"sec-edgar","filing":"0001493152-20-022148","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220022148/ownership.xml","form_type":"4"}},{"id":3008892,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2020-10-13T22:27:28.000Z","date":"2020-10-09","kind":"grant","acquired":true,"shares":143182,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest 50% on March 31, 2021, and 50% on September 30, 2021."}],"balance_after":196736,"source":{"system":"sec-edgar","filing":"0001493152-20-019384","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220019384/ownership.xml","form_type":"4"}},{"id":3138306,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-05-22T22:07:45.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":28919,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options will vest 25% on March 16, 2021, and in 36 equal monthly installments\nthereafter."}],"balance_after":28919,"derivative":{"exercise_price":3.2,"expiration_date":"2030-05-20","underlying":"Common Stock","underlying_shares":28919},"source":{"system":"sec-edgar","filing":"0001493152-20-009758","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220009758/ownership.xml","form_type":"4"}},{"id":3138305,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2020-05-22T22:07:45.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock will vest 25% on March 31, 2021, and in three equal annual\ninstallments thereafter."}],"balance_after":53554,"source":{"system":"sec-edgar","filing":"0001493152-20-009758","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220009758/ownership.xml","form_type":"4"}},{"id":3199917,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Abeona Therapeutics Inc. Common Stock","published_at":"2020-03-20T20:14:22.000Z","date":"2020-03-19","kind":"sale","acquired":false,"shares":6446,"price":1.81,"value":11667.26,"ownership":{"direct":true},"balance_after":13554,"source":{"system":"sec-edgar","filing":"0001493152-20-004438","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220004438/ownership.xml","form_type":"4"}},{"id":3203730,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-03-18T20:38:07.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":51081,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Contingent upon stockholder approval of an amendment to the 2015 Equity Incentive Plan (the \"2015 Plan\") at the Annual Meeting of Stockholders scheduled for May 20, 2020 to increase the number of shares available under the 2015 Plan, Mr. Carr will also be entitled to an additional grant of 28,919 stock options and a grant of 40,000 shares of restricted stock as soon as practicable after the amendment of the 2015 Plan. The stock options contingent upon stockholder approval will have an exercise price determined at the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest 25% on March 16, 2021, and in 36 equal monthly installments thereafter."}],"balance_after":51081,"derivative":{"exercise_price":1.45,"expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":51081},"source":{"system":"sec-edgar","filing":"0001493152-20-004256","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315220004256/ownership.xml","form_type":"4"}},{"id":3414457,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Abeona Therapeutics Inc. Common Stock","published_at":"2019-09-16T21:51:15.000Z","date":"2019-09-12","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The award was granted under the Abeona Therapeutics Inc. Equity Incentive Plan and will vest 100% on March 12, 2020."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001144204-19-044759","document":"tv529533_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000114420419044759/tv529533_4.xml","form_type":"4"}},{"id":3553077,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-04-18T21:57:51.000Z","date":"2018-11-19","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest 25% on November 19, 2019, and in 36 equal monthly installments thereafter."}],"balance_after":35000,"derivative":{"exercise_price":8.54,"expiration_date":"2028-11-19","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001144204-19-020315","document":"tv519200_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000114420419020315/tv519200_4.xml","form_type":"4"}},{"id":3558038,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":60984,"kind":"person","name":"CARR EDWARD","position":1,"cik":"0001273351","reported_name":"CARR EDWARD","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Accounting Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-04-11T22:57:10.000Z","date":"2019-04-09","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest 25% on April 9, 2020, and in 36 equal monthly installments thereafter."}],"balance_after":10000,"derivative":{"exercise_price":7.24,"expiration_date":"2029-04-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001144204-19-019353","document":"tv518745_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000114420419019353/tv518745_4.xml","form_type":"4"}}]}